| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/20/2005 | CN1640406A Drug-dropping and intelligence-promoting medicine using ocotillol as effective component, and its preparing method and use |
| 07/20/2005 | CN1640405A Method for producing d-alpha-succinic tocopherol granule |
| 07/20/2005 | CN1640404A Ganciclovir injection liquid and its production method |
| 07/20/2005 | CN1640402A Stable naloxone powder for injection |
| 07/20/2005 | CN1640400A Felodipine controlled-release preparation |
| 07/20/2005 | CN1640398A Paracetamol hydrochloride and dextromethorphan hydrochloride orally disintegrating tablet and its preparing method |
| 07/20/2005 | CN1640397A Kurarinol drop pill and its preparing method |
| 07/20/2005 | CN1640396A Novel medicinal compositions |
| 07/20/2005 | CN1640395A Supermolecular intercalation-structure slow-release captopril and its preparing method |
| 07/20/2005 | CN1640394A Andrographolide sulfonic acid sodium lyophilized powder for injection and its preparing method |
| 07/20/2005 | CN1640392A High-dose hydroxy safflower yellow A or its medically-acceptable salt application for preparing medicine for cerebral apoplexy induced from being ischemic |
| 07/20/2005 | CN1640391A Tanshinon IIA sulfonic acid sodium glucose injection liquid and its preparing method |
| 07/20/2005 | CN1640390A Novel sodium houttuynin lyophilized powder for injection and its preparing method |
| 07/20/2005 | CN1640388A Tulobuterol containing pressure-sensitive adhesive, transdermal paster, and its preparing method and use |
| 07/20/2005 | CN1640387A Intradermal absorbing paster and its preparing method |
| 07/20/2005 | CN1640386A Oral solid medicine release system |
| 07/20/2005 | CN1640385A Magnetic medicinal microball for directional breaking nerve back root and its preparing method |
| 07/20/2005 | CN1640376A Chinese medicine hand-held health-care ball |
| 07/20/2005 | CN1211368C Amorphous torasemide modification |
| 07/20/2005 | CN1211164C Medium milling |
| 07/20/2005 | CN1211127C Nanoscale particles having iron oxide-containing core enveloped by at least two shells |
| 07/20/2005 | CN1211125C Olopatadine formulations for topical administration |
| 07/20/2005 | CN1211124C Thixotropic formulations for filling hard capsules |
| 07/20/2005 | CN1211119C Compound pill medicine for treating hemorrhoids and use |
| 07/20/2005 | CN1211117C Preparation of Xinxue granules |
| 07/20/2005 | CN1211116C Medicine for treating sympthetic nerve disorder |
| 07/20/2005 | CN1211115C Chinese materia medica preparation for treating burn and scald and method for preparing the same |
| 07/20/2005 | CN1211086C Sustained release ranolazine formulations |
| 07/20/2005 | CN1211085C Compositions having improved stability |
| 07/20/2005 | CN1211084C Technology for producing Dekualinum lozenge |
| 07/20/2005 | CN1211081C Use of Tamsulosin preparing preparations for treating neurogenic bladder associated dysuria |
| 07/20/2005 | CN1211080C Method for preparing microcapsule |
| 07/20/2005 | CN1211079C Stable slow-releasing oral administration composition |
| 07/20/2005 | CN1211078C Regulated release preparations |
| 07/20/2005 | CN1211077C Histamine H2 antagonist effervescent composition |
| 07/20/2005 | CN1211076C Delivery systems using preformed biodegradable polymer compositions and methods |
| 07/20/2005 | CN1211075C Method for using nano technological process to prepare Chinese medicinal material and health-care food ultramicroparticles |
| 07/20/2005 | CN1211074C Solid-state liposome contaniing calcareous and its preparation method |
| 07/20/2005 | CN1211073C Process for preparing ceramide liposome emulsion |
| 07/20/2005 | CN1211072C Snake wine |
| 07/20/2005 | CN1211070C Facial tissue compsn. and method of use for sequestration of nasal secretion skin irritants |
| 07/20/2005 | CN1211058C Container for oxazolidone intravenous solution and method for preventing loss of oxazolidone |
| 07/19/2005 | US6919378 Pharmaceutical solutions of modafinil compounds |
| 07/19/2005 | US6919373 Methods and devices for providing prolonged drug therapy |
| 07/19/2005 | US6919372 An ionic prostanoic acid derivative, for which sustained release is required through parenteral route, and an cationic compound form a sparingly water-soluble ionic complex; increased occtanol/water partition coefficient; hydrophobic |
| 07/19/2005 | US6919370 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
| 07/19/2005 | US6919350 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| 07/19/2005 | US6919348 1-R1- phenyl, 4-R2-phenyl substituted 1,2,3,6-tetrahydropyrimidine-2- one cold receptor agonist in a therapeutically effective amount and preferably further comprises one or more pharmaceutically active drugs such as |
| 07/19/2005 | US6919325 Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts |
| 07/19/2005 | US6919321 Ophthalmic lubricating solution adapted for use in lasik surgery |
| 07/19/2005 | US6919312 Polysaccharides |
| 07/19/2005 | US6919093 Formulation |
| 07/19/2005 | US6919092 Method for the management of incontinence |
| 07/19/2005 | US6919088 Water-soluble stable salts of petroselinic acid |
| 07/19/2005 | US6919087 And an excipient wherein the pH is within the range of 5.5-7.0; stability; dosage forms |
| 07/19/2005 | US6919069 Aerosol formulation containing particulate formoterol, propellant and polar cosolvent |
| 07/19/2005 | US6919067 Compositions comprising a tissue glue and therapeutic agents |
| 07/19/2005 | US6918991 Methods and apparatus for making particles using spray dryer and in-line jet mill |
| 07/19/2005 | US6918869 System for administering a combination of therapies to a body lumen |
| 07/14/2005 | WO2005064338A1 Microparticles for use in diagnostic methods |
| 07/14/2005 | WO2005063777A1 Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation |
| 07/14/2005 | WO2005063318A1 Stent with therapeutically active drug coated thereon |
| 07/14/2005 | WO2005063298A1 Stable growth hormone liquid formulation |
| 07/14/2005 | WO2005063291A1 Stable water-based medicinal preparation containing antibody |
| 07/14/2005 | WO2005063288A1 Synergistic liposomal adjuvants |
| 07/14/2005 | WO2005063287A1 Proteoliposomes and derivatives thereof as cytotoxic response-inducing adjuvants and resulting formulations |
| 07/14/2005 | WO2005063276A1 Methods and compositions using gonadotropin hormone releasing hormone |
| 07/14/2005 | WO2005063267A1 The oral disintegratable tablet of ginkgo leaves |
| 07/14/2005 | WO2005063256A2 Coating method |
| 07/14/2005 | WO2005063232A1 Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity |
| 07/14/2005 | WO2005063229A1 Pregabalin composition |
| 07/14/2005 | WO2005063225A1 Compositions and methods for treating hepatitis c virus (hcv) infection |
| 07/14/2005 | WO2005063219A2 Ibuprofen-containing soft gelatin capsules |
| 07/14/2005 | WO2005063218A2 Pharmaceutical formulations of bisphosphonates |
| 07/14/2005 | WO2005063217A1 Oral medicament delivery system comprising collagen-based fibrous matrix |
| 07/14/2005 | WO2005063216A1 Use-activated plaster |
| 07/14/2005 | WO2005063215A1 Anti-inflammatory analgesic external preparation |
| 07/14/2005 | WO2005063214A1 Method for the production of an administration form which is secured against misuse |
| 07/14/2005 | WO2005063213A1 Rigid liposomal cochleate and methods of use and manufacture |
| 07/14/2005 | WO2005063212A1 Cholesteryl hemisuccinate incorporated lipid-based nano-carriers and skin-care compositions for external application containing the same |
| 07/14/2005 | WO2005063211A2 Method of producing lipid complexed camptothecin-carboxylate |
| 07/14/2005 | WO2005063210A2 Loading of a camptothecin drug into colloidal nanoparticles |
| 07/14/2005 | WO2005063209A1 Self-microemulsifying drug delivery systems of a hiv protease inhibitor |
| 07/14/2005 | WO2005063208A1 Consumer customized dosage forms |
| 07/14/2005 | WO2005063207A1 Nonaqueous gel preparation for external use |
| 07/14/2005 | WO2005063206A1 Methods and dosage forms for increasing solubility of drug compositions for controlled delivery |
| 07/14/2005 | WO2005063205A2 Injectable phosphatidylcholine preparations |
| 07/14/2005 | WO2005063204A2 Drug delivery device with suture ring |
| 07/14/2005 | WO2005063203A2 Multiparticulate formulations for oral delivery |
| 07/14/2005 | WO2005063202A2 Method for preparing solid dosage form of desmopressin |
| 07/14/2005 | WO2005063201A2 Liposomes and liposomal compositions for vaccination and drug delivery |
| 07/14/2005 | WO2005063200A2 Probiotic tablet formulations |
| 07/14/2005 | WO2005063199A1 Effervescent preparation of a basic medicinal substance |
| 07/14/2005 | WO2005063190A1 Sunscreen composition comprising a mixture of silicas |
| 07/14/2005 | WO2005063186A1 Herbal oro-dental care composition and process for preparing the same |
| 07/14/2005 | WO2005063156A1 Oral peptide delivery system with improved bioavailability |
| 07/14/2005 | WO2005063147A1 Use of alginate matrices to control cell growth |
| 07/14/2005 | WO2005063016A1 Multiphase active ingredient formulation |
| 07/14/2005 | WO2005062898A2 Enhanced absorption of modified release dosage forms |
| 07/14/2005 | WO2005062818A2 Treatment of ophthalmic conditions |